Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease

Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. A previous rat study revealed an ADMA lowering effect following treatment with omega-3 polyunsaturated fatty acids (n-3 PUFAs). We sought to examine if an association between plasma ADMA and risk of a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Borgeraas, Heidi, Strand, Elin, Ringdal Pedersen, Eva, Dierkes, Jutta, Ueland, Per Magne, Seifert, Reinhard, Wilberg, Eirik Rebnord, Bohov, Pavol, Berge, Rolf K., Nilsen, Dennis W. T., Nygård, Ottar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3549394/
https://ncbi.nlm.nih.gov/pubmed/23346455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/201742
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak